<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=mp%3AV2.0.0_testgegevens_medicatiegegevens_ontvangen_TA</id>
	<title>mp:V2.0.0 testgegevens medicatiegegevens ontvangen TA - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=mp%3AV2.0.0_testgegevens_medicatiegegevens_ontvangen_TA"/>
	<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;action=history"/>
	<updated>2026-05-27T02:39:53Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=131026&amp;oldid=prev</id>
		<title>Marijke van Geijn op 2 sep 2022 om 13:26</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=131026&amp;oldid=prev"/>
		<updated>2022-09-02T13:26:46Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 2 sep 2022 13:26&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l3&quot;&gt;Regel 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario&#039;s]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Inleiding ==  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Inleiding ==  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=107382&amp;oldid=prev</id>
		<title>Marijke van Geijn op 4 apr 2022 om 11:29</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=107382&amp;oldid=prev"/>
		<updated>2022-04-04T11:29:49Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 4 apr 2022 11:29&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{IssueBox|Deze pagina is nog in bewerking}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;__NUMBEREDHEADINGS__&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l176&quot;&gt;Regel 176:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 174:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| Datum||Omschrijving&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| Datum||Omschrijving&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;| &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2022-04-05&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;|&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;| &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;publicatie&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=102922&amp;oldid=prev</id>
		<title>Marijke van Geijn: /* Scenarioset 3: stop-toedieningsafspraken (staken, wijzigen, onderbreken) */</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=102922&amp;oldid=prev"/>
		<updated>2022-03-10T13:49:57Z</updated>

		<summary type="html">&lt;p&gt;&lt;span class=&quot;autocomment&quot;&gt;Scenarioset 3: stop-toedieningsafspraken (staken, wijzigen, onderbreken)&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 10 mrt 2022 13:49&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l82&quot;&gt;Regel 82:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 82:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Scenario’s ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Scenario’s ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;font color=#FF0000&amp;gt;LET OP: onderstaande scenario&#039;s &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;dienen te worden uitgevoerd op de reeds in scenario 2.1, 2.2, 2.3 en 2.4 aangemaakte afspraken&lt;/del&gt;.&amp;lt;/font&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;font color=#FF0000&amp;gt;LET OP: onderstaande scenario&#039;s &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;bevatten toedieningsafspraken welke gestopt (tijdelijk/definitief) of gewijzigd zijn&lt;/ins&gt;.&amp;lt;/font&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=96289&amp;oldid=prev</id>
		<title>Marijke van Geijn op 28 feb 2022 om 10:26</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=96289&amp;oldid=prev"/>
		<updated>2022-02-28T10:26:42Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 28 feb 2022 10:26&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l52&quot;&gt;Regel 52:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 52:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset1-1-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset1&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-1-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-1-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-2a }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-1-2a }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-2b }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-1-2b }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-1-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-4 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-1-4 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l68&quot;&gt;Regel 68:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 68:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset2-2-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset2&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-2-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-2-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-2 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-2-2 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-2-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-4 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-2-4 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-5 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-2-5 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l86&quot;&gt;Regel 86:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 86:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset3-3-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-3-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-3-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-2 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-3-2 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-3-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-4 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-3-4 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-5 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-3-5 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l112&quot;&gt;Regel 112:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 112:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset6-6-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-2 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-2 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-4 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-4 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-5 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-5 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-6 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-6 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-7a }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-7a }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-7b }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-7b }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-8 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-8 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-9 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-9 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-10 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-10 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-11 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-11 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-12 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-12 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-13 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-13 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-14 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-14 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-15 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-6-15 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l139&quot;&gt;Regel 139:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 139:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset7-7-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset7&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-7-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-7-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-7-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-7-2 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-7-2 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-7-3 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-7-3 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l163&quot;&gt;Regel 163:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 163:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== Inhoudelijke gegevens ===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset10-10-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset10&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-10-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset10-10-1 }}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset10&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-v20&lt;/ins&gt;-10-1 }}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;br&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=95800&amp;oldid=prev</id>
		<title>Marijke van Geijn op 8 feb 2022 om 14:01</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=95800&amp;oldid=prev"/>
		<updated>2022-02-08T14:01:14Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 8 feb 2022 14:01&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;m&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{IssueBox|Deze pagina is nog in bewerking}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{IssueBox|Deze pagina is nog in bewerking}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=95797&amp;oldid=prev</id>
		<title>Marijke van Geijn: Nieuwe pagina aangemaakt met &#039;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}} m {{IssueBox|Deze pagina is nog in bewerking}}  __NUMBERE...&#039;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_ontvangen_TA&amp;diff=95797&amp;oldid=prev"/>
		<updated>2022-02-08T13:58:25Z</updated>

		<summary type="html">&lt;p&gt;Nieuwe pagina aangemaakt met &amp;#039;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}} m {{IssueBox|Deze pagina is nog in bewerking}}  __NUMBERE...&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nieuwe pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens ontvangend systeem (TA)}}&lt;br /&gt;
m&lt;br /&gt;
{{IssueBox|Deze pagina is nog in bewerking}}&lt;br /&gt;
&lt;br /&gt;
__NUMBEREDHEADINGS__&lt;br /&gt;
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]&lt;br /&gt;
&lt;br /&gt;
== Inleiding == &lt;br /&gt;
Dit document biedt de mogelijkheid voor het testen van de systeemrol:&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;M&amp;#039;&amp;#039;&amp;#039;edicatie&amp;#039;&amp;#039;&amp;#039;G&amp;#039;&amp;#039;&amp;#039;egevens &amp;#039;&amp;#039;&amp;#039;O&amp;#039;&amp;#039;&amp;#039;ntvangend systeem (MP-MGO) &amp;#039;&amp;#039;&amp;#039;toedieningsafspraak&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;.&lt;br /&gt;
&lt;br /&gt;
De doelgroep van dit document is de leverancier die &amp;#039;&amp;#039;&amp;#039;zelfstandig testen uitvoert ter voorbereiding op de kwalificatie&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
&amp;lt;br&amp;gt; Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). &amp;lt;br&amp;gt;&lt;br /&gt;
Deze aanpassingen worden vermeld in de documenthistorie.&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl&lt;br /&gt;
&lt;br /&gt;
== Uit te voeren stappen ==&lt;br /&gt;
&lt;br /&gt;
Voer – voor ieder scenario in de &amp;#039;Scenarioset&amp;#039; hoofdstukken – de volgende stappen uit:&lt;br /&gt;
# De simulator verstuurt een ‘Medicatiegegevens sturen’ bericht voor de persoon genoemd in Persoonsgegevens.&lt;br /&gt;
# Ontvang het ‘Medicatiegegevens sturen’ bericht en toon de gegevens uit het bericht op het scherm.&lt;br /&gt;
# Beantwoord de kwalificatiesimulator met een ‘ontvangstbevestiging’ bericht.&lt;br /&gt;
&lt;br /&gt;
== Leeswijzer ==&lt;br /&gt;
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:&lt;br /&gt;
# Scenario’s&lt;br /&gt;
# Inhoudelijke gegevens&lt;br /&gt;
&lt;br /&gt;
===Scenario&amp;#039;s===&lt;br /&gt;
In deze paragraaf zijn alle scenario&amp;#039;s van het betreffende hoofdstuk beschreven. &amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
De kolom &amp;#039;beschrijving&amp;#039; geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.&amp;lt;br&amp;gt;&lt;br /&gt;
Bij elk scenario staan de id&amp;#039;s van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf &amp;quot;Inhoudelijke gegevens&amp;quot; van het betreffende hoofdstuk.&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens ontvangend systeem. Dit zijn de gegevens voor toedieningsafspraak.&lt;br /&gt;
&lt;br /&gt;
=== Gebruikersschermen===&lt;br /&gt;
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.&lt;br /&gt;
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.&lt;br /&gt;
&lt;br /&gt;
===Datum T===&lt;br /&gt;
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.&amp;lt;br&amp;gt;&lt;br /&gt;
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} &amp;#039;&amp;#039;&amp;#039;tot en met&amp;#039;&amp;#039;&amp;#039; einddatum {23:59:59}.&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 1: toedieningsafspraak basale inhoud - gebruiksperiode ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-1 }}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset1-1-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-1 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-2a }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-2b }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-3 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-1-4 }}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 2: toedieningsafspraak basale inhoud - andere elementen ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-2 }}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset2-2-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-1 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-2 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-3 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-4 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-2-5 }}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 3: stop-toedieningsafspraken (staken, wijzigen, onderbreken) ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=#FF0000&amp;gt;LET OP: onderstaande scenario&amp;#039;s dienen te worden uitgevoerd op de reeds in scenario 2.1, 2.2, 2.3 en 2.4 aangemaakte afspraken.&amp;lt;/font&amp;gt;&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-3 }}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset3-3-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-1 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-2 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-3 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-4 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-3-5 }}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 4 ==&lt;br /&gt;
Niet van toepassing.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 5 ==&lt;br /&gt;
Niet van toepassing.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 6: toedieningsafspraken met diverse doseerschema&amp;#039;s ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-6 }}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset6-6-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-1 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-2 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-3 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-4 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-5 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-6 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-7a }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-7b }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-8 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-9 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-10 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-11 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-12 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-13 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-14 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-6-15 }}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 7: toedieningsafspraken met magistraal/eigen artikel ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-7 }}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset7-7-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-7-1 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-7-2 }}&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-7-3 }}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 8: andermans toedieningsafspraak ==&lt;br /&gt;
Nog niet van toepassing.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 9 ==&lt;br /&gt;
Niet van toepassing.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Scenarioset 10: toedieningsafspraak o.b.v. ZI-nr ==&lt;br /&gt;
=== Scenario’s ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|overview-MGR-10 }}&lt;br /&gt;
&lt;br /&gt;
=== Inhoudelijke gegevens ===&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset10-10-1 }}&lt;br /&gt;
&lt;br /&gt;
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset10-10-1 }}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Documenthistorie ==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-style=&amp;quot;background-color: #1F497D;; color: white; text-align:left;&amp;quot; &lt;br /&gt;
| Datum||Omschrijving&lt;br /&gt;
|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;br /&gt;
|style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
|style=&amp;quot;background-color: white;&amp;quot;|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;color: #B5B5B5;&amp;quot;&amp;gt;&lt;br /&gt;
Deze pagina maakt gebruik van diverse sections uit addendum &amp;#039;database&amp;#039;: [[mp:V2.0.0_testgegevens_medicatiegegevensMGSMGO_TA_addendum|&amp;lt;font style=&amp;quot;color: #B5B5B5;&amp;quot;&amp;gt;&amp;#039;&amp;#039;testgegevens medicatiegegevens MGS/MGO toedieningsafspraak addendum&amp;#039;&amp;#039;&amp;lt;/font&amp;gt;]]. &amp;lt;/font&amp;gt;&lt;/div&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
</feed>